Financial Instruments and Fair Value Measurements - Additional Information (Details) - USD ($)		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jul. 09, 2020	Jun. 30, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Financial assets measured at fair value on a recurring basis		$ 0	$ 0
Financial liabilities measured at fair value on a recurring basis		0	0
Cash and cash equivalents, consisted of bank deposits		418,000,000	319,000,000
Long-term marketable securities outstanding		0	0
Short-term marketable securities outstanding		0	0
Marketable securities, realized gain (losses)		$ 0	0
Derivative instruments not designated as hedging instruments, description of terms		We generally use forward contracts to reduce the effects of foreign currency exchange rate fluctuations on our cash flows primarily for the Euro versus the U.S. Dollar. For the periods ended December 31, 2020, 2019 and 2018, respectively, our forward contracts have not been designated as hedges and generally had maturities of less than 90 days.
Foreign currency exchange contracts maturity period, maximum		90 days
Net gain (loss) related to forward contracts		$ 1,000,000	1,000,000	$ (3,000,000)
Senior notes, carrying value		491,000,000
Deferred income liability	[1]	33,000,000	36,000,000
Earnings (losses) from equity method investment, net		(3,000,000)	(1,000,000)
Equity securities without readily determinable fair value		$ 2,000,000	14,000,000
Redemption value of shares in return for collateralized note receivable						$ 10,000,000
Other Long-Term Assets
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Redeemable noncontrolling interest, settlement amount						$ 20,000,000
Percentage of notes receivable due in 5 years		50.00%
Percentage of notes receivable due in 10 years		50.00%
Allowance for credit loss under ASC 326		$ 3,000,000
Net of accumulated allowance for credit losses, Carrying value		$ 14,000,000
Chelsea Investment Holding Company PTE, Ltd
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Equity method investment, ownership percentage		40.00%
Equity method investments			41,000,000
Deferred income liability			39,000,000
Deferred gain recognition period		15 years
Impairment loss on equity method investments		$ 0	0
Chelsea Investment Holding Company PTE, Ltd | Non-Marketable Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Equity method investments		38,000,000	41,000,000
Chelsea Investment Holding Company PTE, Ltd | Accrued Expenses and Other Current Liabilities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Deferred income liability		3,000,000
Chelsea Investment Holding Company PTE, Ltd | Other Long-term Liabilities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Deferred income liability		33,000,000
7.000% senior notes due July 15, 2025
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Senior notes, carrying value		491,000,000
Debt instrument, issuances costs					$ 9,000,000
Level 3 Unobservable Inputs
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Financial assets measured at fair value on a recurring basis		0	0
Financial liabilities measured at fair value on a recurring basis		0	$ 0
Level 2 | 7.000% senior notes due July 15, 2025
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Estimated fair value of the outstanding senior notes		542,000,000
Senior notes, carrying value		491,000,000
Debt instrument, issuances costs		$ 9,000,000

[1] Amount relates to long-term portion of a deferred income liability recorded as a result of an equity method investment made in the fourth quarter of 2019. Refer to “Note 5: Financial Instruments and Fair Value Measurements” for additional information.